Propidium Iodide Flow Cytometric Cell-Cycle Analysis of Nocodazole-Induced G2/M Arrest in HeLa Cells with Univariate DNA Content Modeling

Three independent biological replicates on separate days, technical duplicate tubes per condition. Conditions: asynchronous control (vehicle), 100 ng/mL nocodazole (16 h), and a washout-recovery arm (nocodazole 16 h then 8 h drug-free). A minimum of 20,000 single-cell (doublet-discriminated) events collected per tube at a low flow rate (<400 events/s) to preserve coefficient-of-variation (CV) of the G0/G1 peak. PMT voltage set so the G0/G1 peak channel sits near channel 200 (on a 0-1000 linear scale); settings fixed within each experiment.

BSL-2 for HeLa cells; biosafety cabinet for culture and harvest. Propidium iodide is a mutagen and DNA intercalator — handle with gloves and collect PI waste as hazardous. Nocodazole is a toxic antimitotic/teratogen; handle with gloves, avoid aerosols. 70% ethanol is flammable — keep away from ignition sources and store appropriately. RNase A is an irritant. Flow cytometer sheath/waste is biohazard — decontaminate with 10% bleach. Wear lab coat, nitrile gloves, eye protection; autoclave or bleach-treat biological waste; segregate PI/nocodazole chemical waste.

Asynchronous vehicle control defines the baseline cycle distribution and the G0/G1 peak position. DNA-content reference: a known diploid line or DNA QC beads to verify peak channel and instrument linearity. Doublet-discrimination control: gating on PI-area vs PI-width to exclude G0/G1 doublets that masquerade as 4N. No-RNase control demonstrates RNA contribution and justifies RNase treatment. Positive arrest control: nocodazole-treated sample with expected >60% 4N. Single-stain/unstained tube sets baseline autofluorescence and PI threshold.

Asynchronous controls should show a characteristic profile: a dominant G0/G1 (2N) peak (~50-65%), an S-phase shoulder (~10-25%), and a smaller G2/M (4N) peak (~15-25%), with a low CV of the G0/G1 peak (<5-6%, ideally <4%). Nocodazole should produce a striking 4N-dominant profile (>60% G2/M) with G0/G1 depletion. The washout arm should show partial recovery toward the asynchronous profile. A sub-G1 peak indicates apoptotic/fragmented DNA. Clean data have well-separated 2N and 4N peaks and minimal debris.

• HeLa human cervical adenocarcinoma cell line, mycoplasma-tested
• DMEM high-glucose, 10% FBS, 1% penicillin/streptomycin, 2 mM L-glutamine
• Nocodazole, 100 ng/mL working (1 mg/mL stock in DMSO)
• Ice-cold 70% ethanol (fixation/permeabilization)
• Propidium iodide, 50 µg/mL final in staining buffer
• RNase A, 100 µg/mL (DNase-free)
• PBS (Ca2+/Mg2+-free)
• 0.05% trypsin-EDTA
• DMSO vehicle (matched, <=0.1%)
• PI staining buffer: PBS + 0.1% Triton X-100 (optional) + RNase A + PI
• 5 mL round-bottom tubes with 35 µm strainer caps
• DNA QC beads (e.g. linearity/alignment beads) for instrument setup

To measure the distribution of cells across cell-cycle phases by quantitative DNA-content flow cytometry. The protocol fixes and permeabilizes HeLa cells, removes RNA to ensure PI stoichiometry reflects DNA only, and resolves G0/G1 (2N), S (intermediate), and G2/M (4N) populations, demonstrating a quantitative G2/M accumulation after nocodazole-induced microtubule depolymerization.

1. Seed HeLa to ~60-70% confluence; treat with 100 ng/mL nocodazole or DMSO vehicle for 16 h.
2. For the washout arm, remove nocodazole, wash 3x with warm medium, and culture drug-free for 8 h.
3. Harvest by trypsinization (include mitotic round-up/floating cells); pool and count.
4. Wash once in cold PBS; centrifuge 300 x g, 5 min; resuspend ~1-2 x 10^6 cells in 0.5 mL cold PBS.
5. Fix by adding the cell suspension dropwise into 4.5 mL ice-cold 70% ethanol while vortexing gently (prevents clumping); fix >=2 h (or overnight) at 4 C.
6. Centrifuge 500 x g, 5 min (ethanol-fixed cells pellet poorly — use higher g); wash 2x in PBS.
7. Resuspend in 0.5 mL PI staining buffer with 100 µg/mL RNase A and 50 µg/mL PI; incubate 30 min at 37 C (or RT) in the dark.
8. Filter through a 35 µm strainer cap to remove aggregates.
9. Acquire on the cytometer at low flow rate; collect PI signal on a linear scale; record both PI-area (FL2/FL3-A) and PI-width/height for doublet gating.
10. Collect >=20,000 single-cell events per tube.

Independent variable: nocodazole treatment (vehicle, 100 ng/mL 16 h, washout-recovery). Dependent variables: percentage of cells in sub-G1, G0/G1, S, and G2/M phases derived from DNA-content modeling. Controlled variables: fixation method and time (70% ethanol), RNase concentration, PI concentration and incubation, flow rate (<400 events/s), PMT voltage and G0/G1 peak placement, doublet-discrimination gating, cell number per tube, and harvest method (including floating mitotic cells).

We hypothesize that 100 ng/mL nocodazole for 16 h arrests HeLa cells at the G2/M boundary, increasing the 4N (G2/M) fraction from a baseline of approximately 15-25% to greater than 60%, with a corresponding depletion of the G0/G1 (2N) and S populations, and that this arrest is reversible upon nocodazole washout.

FCS files are analyzed in FlowJo (Cell Cycle platform), ModFit LT, or FCS Express. Gating: debris excluded on FSC/SSC -> singlets via PI-area vs PI-width (or area vs height) to remove doublets -> univariate PI-area histogram modeled with the Dean-Jett-Fox or Watson pragmatic algorithm to deconvolve G0/G1, S, and G2/M fractions. Sub-G1 (hypodiploid) events are gated separately to the left of the G0/G1 peak. Reduced chi-square of the model fit is reported; G0/G1 CV is reported as a data-quality metric. The same gating/model template is applied to all files.

1. Broad peaks / high G0/G1 CV (>8%): fix by gentle dropwise ethanol addition with vortexing to prevent clumping, run at a low flow rate, and filter immediately before acquisition. 2. RNA inflating apparent DNA content: ensure DNase-free RNase A is included and incubation is sufficient. 3. 4N peak overestimated by doublets: apply strict area-vs-width doublet discrimination. 4. Poor pellet recovery after ethanol fixation: centrifuge at higher speed (500 x g) and longer, and avoid over-aspirating the soft pellet. 5. Excessive debris/sub-G1 in controls: harvest gently, avoid over-trypsinization, and use healthy log-phase cultures; confirm sub-G1 is biological (apoptosis) not mechanical fragmentation.

Phase percentages (mean of technical duplicates, n = 3 biological replicates) are compared across conditions by two-way ANOVA (phase x treatment) with Tukey's HSD correction, alpha = 0.05; the G2/M fraction is the primary endpoint and is compared by one-way ANOVA with Dunnett's test versus vehicle. Effect of washout is tested against nocodazole alone by paired t-test. With n = 3 and an expected >35-percentage-point G2/M increase (large effect), power exceeds 0.9. Model-fit chi-square and G0/G1 CV are reported as QC, not as inferential statistics.